MyAverix Finance
SHG · Healthcare
HPGC Renmintongtai Pharmaceutical Corp (600829)
Drug Manufacturers - Specialty & Generic
HPGC Renmintongtai Pharmaceutical Corp (600829) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $5.81B, P/E ratio is 47.71, net margin is 1.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 600829
HPGC Renmintongtai Pharmaceutical Corp (600829) — FAQ
What is HPGC Renmintongtai Pharmaceutical Corp's market cap?
HPGC Renmintongtai Pharmaceutical Corp (600829) has a reported market cap of $5.81B (data as of 2026-03-28).
What is 600829's P/E ratio?
The price-to-earnings (P/E) ratio for HPGC Renmintongtai Pharmaceutical Corp (600829) is 47.71 (data as of 2026-03-28).
Does HPGC Renmintongtai Pharmaceutical Corp pay a dividend?
Dividend yield is not available in the current snapshot for HPGC Renmintongtai Pharmaceutical Corp (600829). Check the MyAverix Finance app for the latest dividend data.
What sector is HPGC Renmintongtai Pharmaceutical Corp in?
HPGC Renmintongtai Pharmaceutical Corp (600829) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 600829 listed on?
600829 is listed on SHG.
What is HPGC Renmintongtai Pharmaceutical Corp's net margin?
HPGC Renmintongtai Pharmaceutical Corp (600829) reports a net margin of 1.2% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.